Indeed, inhibiting MDM2 by genetic strategy confirmed the pivotal role of MDM2 in mediating high glucose-induced cell proliferation and ECM accumulation in GMCs, which are two crucial events leading to glomerulosclerosis in DKD. This evidence concerns the gene MDM2 and diabetic kidney disease.